Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;6(7):484-494.
doi: 10.1016/S2352-4642(22)00098-0. Epub 2022 May 12.

Epilepsy surgery for children and adolescents: evidence-based but underused

Affiliations
Review

Epilepsy surgery for children and adolescents: evidence-based but underused

J Helen Cross et al. Lancet Child Adolesc Health. 2022 Jul.

Abstract

Paediatric epilepsy surgery is an increasingly used evidence-based management option with low risks for complications. Developments in neuroimaging techniques and other advanced diagnostics have widened the spectrum of children who could benefit from the procedure, and surgery is now considered a standard management approach for epilepsy. Available data indicate that early surgery improves outcomes. Despite these considerable advances, epilepsy surgery in children is still underused. In this Review, we summarise the indications, patient selection, principles of presurgical investigations, optimal timing, and types of epilepsy surgery. We also examine comprehensive outcomes after surgery, including seizure outcomes, complications, cognition, neurodevelopment, vocational outcome, and health-related quality of life of children and their parents. Successful epilepsy surgery could lead to improvement in all these areas. Children should, therefore, be referred early for evaluation in an appropriately competent centre.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests JHC has acted as an investigator for studies with GW Pharma, Zogenix, Vitaflo, Ovid, Marinius, and Stoke Therapeutics. JHC has been a speaker and on advisory boards for GW Pharma, Biocodex, Zogenix, and Nutricia (all remuneration has been paid to her department). CR has been a speaker for GW Pharma. EGD, MLS, and KM declare no competing interests.

Publication types